BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

228 related articles for article (PubMed ID: 29867928)

  • 1. Polymorphism rs1385129 Within Glut1 Gene
    Masson JJR; Cherry CL; Murphy NM; Sada-Ovalle I; Hussain T; Palchaudhuri R; Martinson J; Landay AL; Billah B; Crowe SM; Palmer CS
    Front Immunol; 2018; 9():900. PubMed ID: 29867928
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Metabolically active CD4+ T cells expressing Glut1 and OX40 preferentially harbor HIV during in vitro infection.
    Palmer CS; Duette GA; Wagner MCE; Henstridge DC; Saleh S; Pereira C; Zhou J; Simar D; Lewin SR; Ostrowski M; McCune JM; Crowe SM
    FEBS Lett; 2017 Oct; 591(20):3319-3332. PubMed ID: 28892135
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of polymorphisms in the HCP5 and HLA-C, and ZNRD1 genes on HIV viral load.
    Thørner LW; Erikstrup C; Harritshøj LH; Larsen MH; Kronborg G; Pedersen C; Larsen CS; Pedersen G; Gerstoft J; Obel N; Ullum H
    Infect Genet Evol; 2016 Jul; 41():185-190. PubMed ID: 27083073
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Polymorphism in interleukin-7 receptor α gene is associated with faster CD4⁺ T-cell recovery after initiation of combination antiretroviral therapy.
    Hartling HJ; Thørner LW; Erikstrup C; Harritshøj LH; Kronborg G; Pedersen C; Larsen CS; Helleberg M; Gerstoft J; Obel N; Ullum H; Nielsen SD
    AIDS; 2014 Jul; 28(12):1739-48. PubMed ID: 24911352
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Polymorphisms in the CD14 and TLR4 genes independently predict CD4+ T-cell recovery in HIV-infected individuals on antiretroviral therapy.
    Yong YK; Shankar EM; Solomon A; Spelman T; Fairley CK; Elliott JH; Hoy J; Cameron PU; Kamarulzaman A; Lewin SR
    AIDS; 2016 Sep; 30(14):2159-68. PubMed ID: 27281059
    [TBL] [Abstract][Full Text] [Related]  

  • 6.
    Resino S; Navarrete-Muñoz MA; Blanco J; Pacheco YM; Castro I; Berenguer J; Santos J; Vera-Méndez FJ; Górgolas M; Jiménez-Sousa MAÁ; Benito JM; Rallón N;
    Biomolecules; 2019 Jun; 9(6):. PubMed ID: 31208153
    [TBL] [Abstract][Full Text] [Related]  

  • 7. IL7RA polymorphisms predict the CD4+ recovery in HIV patients on cART.
    Guzmán-Fulgencio M; Berenguer J; Jiménez-Sousa MA; Micheloud D; García-Álvarez M; Bellón JM; Aldámiz-Echevarría T; García-Broncano P; Catalán P; Diez C; Pineda-Tenor D; Resino S
    Eur J Clin Invest; 2015 Nov; 45(11):1192-9. PubMed ID: 26402121
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Assessment of metabolic and mitochondrial dynamics in CD4+ and CD8+ T cells in virologically suppressed HIV-positive individuals on combination antiretroviral therapy.
    Masson JJR; Murphy AJ; Lee MKS; Ostrowski M; Crowe SM; Palmer CS
    PLoS One; 2017; 12(8):e0183931. PubMed ID: 28854263
    [TBL] [Abstract][Full Text] [Related]  

  • 9. IL18 gene polymorphism and its influence on CD4+ T-cell recovery in HIV-positive patients receiving antiretroviral therapy.
    Andrade-Santos JL; Carvalho-Silva WHV; Coelho AVC; Souto FO; Crovella S; Brandão LAC; Guimarães RL
    Infect Genet Evol; 2019 Nov; 75():103997. PubMed ID: 31401307
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immune signatures for HIV-1 and HIV-2 induced CD4
    Salwe S; Singh A; Padwal V; Velhal S; Nagar V; Patil P; Deshpande A; Patel V
    BMC Infect Dis; 2019 Feb; 19(1):135. PubMed ID: 30744575
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Does rapid HIV disease progression prior to combination antiretroviral therapy hinder optimal CD4+ T-cell recovery once HIV-1 suppression is achieved?
    Jarrin I; Pantazis N; Dalmau J; Phillips AN; Olson A; Mussini C; Boufassa F; Costagliola D; Porter K; Blanco J; Del Amo J; Martinez-Picado J;
    AIDS; 2015 Nov; 29(17):2323-33. PubMed ID: 26544704
    [TBL] [Abstract][Full Text] [Related]  

  • 12. European mitochondrial haplogroups are associated with CD4+ T cell recovery in HIV-infected patients on combination antiretroviral therapy.
    Guzmán-Fulgencio M; Berenguer J; Micheloud D; Fernández-Rodríguez A; García-Álvarez M; Jiménez-Sousa MA; Bellón JM; Campos Y; Cosín J; Aldámiz-Echevarría T; Catalán P; López JC; Resino S
    J Antimicrob Chemother; 2013 Oct; 68(10):2349-57. PubMed ID: 23749950
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gene variation in IL-7 receptor (IL-7R)α affects IL-7R response in CD4+ T cells in HIV-infected individuals.
    Hartling HJ; Ryder LP; Ullum H; Ødum N; Nielsen SD
    Sci Rep; 2017 Feb; 7():42036. PubMed ID: 28181541
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impaired gut junctional complexes feature late-treated individuals with suboptimal CD4+ T-cell recovery upon virologically suppressive combination antiretroviral therapy.
    Tincati C; Merlini E; Braidotti P; Ancona G; Savi F; Tosi D; Borghi E; Callegari ML; Mangiavillano B; Barassi A; Bulfamante G; d'Arminio Monforte A; Romagnoli S; Chomont N; Marchetti G
    AIDS; 2016 Apr; 30(7):991-1003. PubMed ID: 27028142
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impaired CD4+ T-cell restoration in the small versus large intestine of HIV-1-positive South Africans receiving combination antiretroviral therapy.
    Cassol E; Malfeld S; Mahasha P; Bond R; Slavik T; Seebregts C; Poli G; Cassol S; van der Merwe SW; Rossouw T
    J Infect Dis; 2013 Oct; 208(7):1113-22. PubMed ID: 23749968
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Low CD4 T-cell counts despite low levels of circulating HIV: insights from the comparison of HIV-1 infected patients with a discordant response to antiretroviral therapy to patients with untreated advanced HIV-2 disease.
    Albuquerque AS; Foxall RB; Cortesão CS; Soares RS; Doroana M; Ribeiro A; Lucas M; Antunes F; Victorino RM; Sousa AE
    Clin Immunol; 2007 Oct; 125(1):67-75. PubMed ID: 17692571
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increased glucose metabolic activity is associated with CD4+ T-cell activation and depletion during chronic HIV infection.
    Palmer CS; Ostrowski M; Gouillou M; Tsai L; Yu D; Zhou J; Henstridge DC; Maisa A; Hearps AC; Lewin SR; Landay A; Jaworowski A; McCune JM; Crowe SM
    AIDS; 2014 Jan; 28(3):297-309. PubMed ID: 24335483
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Determinants of CD4+ T cell recovery during suppressive antiretroviral therapy: association of immune activation, T cell maturation markers, and cellular HIV-1 DNA.
    Goicoechea M; Smith DM; Liu L; May S; Tenorio AR; Ignacio CC; Landay A; Haubrich R
    J Infect Dis; 2006 Jul; 194(1):29-37. PubMed ID: 16741879
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Course and Clinical Significance of CD8+ T-Cell Counts in a Large Cohort of HIV-Infected Individuals.
    Helleberg M; Kronborg G; Ullum H; Ryder LP; Obel N; Gerstoft J
    J Infect Dis; 2015 Jun; 211(11):1726-34. PubMed ID: 25489001
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of Interleukin-28B polymorphism on Interleukin-28 expression and immunological recovery amongst HIV-1-infected individuals following antiretroviral therapy.
    Srinidhi BV; Fletcher GJ; Sachidanantham J; Rupali P; Ramalingam VV; Demosthenes JP; Abraham OC; Pulimood SA; Rebekah G; Kannangai R
    Indian J Med Microbiol; 2017; 35(4):580-584. PubMed ID: 29405153
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.